Manea-DT: A Potential Drug Target for Cancer and Inflammatory Diseases

Target Name: MANEA-DT

NCBI ID: G101927288

MANEA-DT

Manea-DT: A Potential Drug Target for Cancer and Inflammatory Diseases

MANEA-DT (Methionyl-?±-Naphthalene-1-Sulfonate) is a drug target (also known as a biomarker) that has been shown to have potential in treating various diseases, including cancer. Manea-DT is a derivative of naphthalene, which is a natural compound that has been found to have anti-inflammatory and antioxidant properties.

One of the main reasons for the potential of Manea-DT as a drug target is its unique mechanism of action. Unlike many other drugs that target specific proteins or molecules, Manea-DT works by modulating the levels of different metabolites within cells. Specifically, it appears to increase the levels of a metabolite called 7-?±-Hydroxy-Naphthalene-1-Sulfonate (7-?±-HNS), which has been shown to have a number of potential health benefits.

7-?±-HNS is a metabolite that is produced when naphthalene is metabolized by the enzyme cytochrome P450 (CYP) enzymes. In previous studies, researchers have shown that 7-?±-HNS has a number of potential health benefits, including anti-inflammatory effects, antioxidant properties, and potential neuroprotective effects.

One of the key reasons for the potential of Manea-DT as a drug target is its ability to increase the levels of 7-?±-HNS in cells. This is because the levels of 7-?±-HNS in cells can be affected by a number of different factors, including the levels of the enzymes that metabolize it. By increasing the levels of 7-?±-HNS, Manea-DT appears to be able to modulate the activity of these enzymes and ultimately have a number of different effects on the cell.

Another potential advantage of Manea-DT as a drug target is its ability to selectively target certain types of cells. While it is not yet clear exactly how Manea-DT works at the molecular level, it appears to be able to selectively target cells that are rich in certain metabolites or have certain characteristics. This could allow for a more targeted and effective treatment of certain diseases.

In addition to its potential as a drug target, Manea-DT also has a number of potential biological applications. For example, it has been shown to have anti-inflammatory effects and may be able to be used as a treatment for a variety of inflammatory conditions. It has also been shown to have antioxidant properties and may be able to protect cells from damage caused by free radicals.

While the exact mechanism of action of Manea-DT is not yet fully understood, it is clear that it has a number of potential health benefits. As research continues to advance, it is likely that Manea-DT will be shown to be a valuable drug target and may be used to treat a variety of diseases.

Protein Name: MANEA Divergent Transcript

The "MANEA-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MANEA-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets